Anti-carbamylated protein and peptide antibodies as potential inflammatory joint biomarkers in the relatives of rheumatoid arthritis patients.
Lorena Chila-MorenoLuz-Stella RodríguezWilson Bautista-MolanoJuan-Manuel Bello-GualteroAlejandro Ramos-CasallasConsuelo Romero-SánchezPublished in: International journal of rheumatic diseases (2020)
The presence of anti-FCS-Carp, anti-Ca-Fib3 and anti-Ca-Fib2 antibodies may have a role for these antibodies as early biomarkers in the development of RA, probably including additional mechanisms related with other non-SE alleles; the anti-peptide antibodies proposed in the present study may represent a simpler way to identify antibodies directed to a specific target.